Ravit Boger

Title: Ravit Boger: Innovator in Virology

Introduction

Ravit Boger is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of virology, particularly in the development of treatments for viral infections. With a total of 7 patents to her name, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents focuses on the use of low-dose emetine for the inhibition of human cytomegalovirus (HCMV). This invention provides methods and compositions that are useful for the prevention and treatment of HCMV. The pharmaceutical composition includes emetine or a derivative, an HCMV drug, and a pharmaceutically acceptable carrier. In specific embodiments, the HCMV drug is ganciclovir, with emetine present at about 1/10 to about 1/100 of the normal dosage for amebiasis. Another notable patent involves ozonides for treating or preventing virus infections, which describes methods of administering ozonides to subjects to combat viral infections.

Career Highlights

Ravit Boger has worked at esteemed institutions such as The Johns Hopkins University and the University of Nebraska. Her experience in these research environments has allowed her to develop innovative solutions to complex medical challenges.

Collaborations

Throughout her career, Ravit has collaborated with notable colleagues, including Marc Ferrer and Juan Jose Marugan. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Ravit Boger is a trailblazer in the field of virology, with a focus on developing effective treatments for viral infections. Her innovative patents and collaborations highlight her commitment to improving public health through scientific research.